Fidelity® Series Intrinsic Opps (FDMLX)
19.61
-0.18 (-0.91%)
USD |
Jan 15
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.01% | 13.52B | 2.26% | 19.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -1.529B | 19.58% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. The fund invests primarily in common stocks. It invests in securities of companies that Fidelity Management & Research Company (FMR) believes are undervalued in the marketplace in relation to factors such as assets, sales, earnings, growth potential, or cash flow, or in relation to securities of other companies in the same industry (stocks of these companies are often called "value" stocks). The fund invests in domestic and foreign issuers. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FDMLX |
| Equity Style | Mid Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Mid-Cap Value |
| Category Index | Russell Mid Cap Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Russell 3000 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Joel Tillinghast | 8.08 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
98
-1.529B
-3.773B
Category Low
1.319B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of December 31, 2020
Performance Versus Category
As of January 15, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of January 15, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
Fidelity Revere Str Tr
|
7.71% | -- | -- |
| Anthem Inc | 5.57% | 326.42 | 1.21% |
|
ITOCHU Corp
|
3.80% | -- | -- |
| MetLife Inc | 2.68% | 51.14 | -0.83% |
| Amgen Inc | 2.53% | 245.49 | 1.58% |
|
JD Sports Fashion PLC
|
2.50% | -- | -- |
| UnitedHealth Group Inc | 2.29% | 351.30 | 0.22% |
| United Therapeutics Corp | 2.11% | 172.82 | 3.32% |
| Synchrony Financial | 1.96% | 38.77 | -0.36% |
| Discover Financial Services | 1.84% | 97.76 | -0.68% |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. The fund invests primarily in common stocks. It invests in securities of companies that Fidelity Management & Research Company (FMR) believes are undervalued in the marketplace in relation to factors such as assets, sales, earnings, growth potential, or cash flow, or in relation to securities of other companies in the same industry (stocks of these companies are often called "value" stocks). The fund invests in domestic and foreign issuers. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FDMLX |
| Equity Style | Mid Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Mid-Cap Value |
| Category Index | Russell Mid Cap Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Russell 3000 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Joel Tillinghast | 8.08 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (1-15-21) | 2.26% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 12.12 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of October 31, 2020
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 12/6/2012 |
| Last Annual Report Date | 7/31/2020 |
| Last Prospectus Date | 9/29/2020 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |